Conferences & Events > Annual Scientific Meeting > Program > Speaker Bios

2020 Annual Scientific Meeting and Symposium Session - Speakers

Opioid Epidemic: Controversies and Creative Solutions

Ilana H. Eisenstein, JD 

Partner, Co-Chair, Appellate Advocacy Practice, DLA Piper

IHE_Headshot.jpgIlana H. Eisenstein is a Partner and Co-Chair of the DLA Piper's Appellate Advocacy Practice, and focuses her law practice on appellate, complex commercial and white-collar litigation. Ms. Eisenstein formerly served 12 years in the U.S. Department of Justice as an Assistant to the U.S. Solicitor General and an Assistant U.S. Attorney. She has argued five cases in the US Supreme Court.
She serves a pro bono counsel for Safehouse in its federal court litigation seeking to establish the first medically supervised consumption site in the United States.

Carla L. Foster, MPH

City Research Scientist, New York City Department of Health and Mental Hygiene

Picture_Foster.jpgCarla is a City Research Scientist at the New York City Department of Health and Mental Hygiene (NYC DOHMH) in the Bureau of Alcohol and Drug Use, Prevention, Care, and Treatment. Her research focuses on the implementation and evaluation of public health detailing campaigns across New York City with the aim of reducing opioid overdose mortality. Prior to joining the NYC DOHMH, she led development of clinical practice guidelines at the American Urological Association. She received dual Bachelor of Arts degrees in Africana Studies and Neuroscience from Wellesley College. Carla also obtained her Master of Public Health Degree in Epidemiology from Columbia University.

Charlotte Goldfine, MD

Emergency Medicine Physician, Division of Medical Toxicology, University of Massachusetts Medical School

charlotte-goldfine.jpgDr. Goldfine is an emergency medicine physician, and a fellow in medical toxicology. She is currently serving as the ACMT Board of Directors fellow-in-training intern and as the ACEP Toxicology Section Newsletter Editor. She completed an Emergency Medicine residency at the University of Connecticut, where she served as chief resident. During medical school, she was awarded as the medical student with the highest humanistic attributes in emergency medicine. In addition, she has studied and worked in Spain, Nicaragua, and most recently the Dominican Republic as an emergency medicine resident. Dr. Goldfine has an interest in medication safety, education, and international medicine.

Lewis Goldfrank, MD, FACMT

Herbert W. Adams Professor of Emergency Medicine, New York University-Bellevue Hospital

no_image.pngComing soon.

Rachel Haroz, MD, FAACT

Assistant Professor of Emergency Medicine, Division Head of Toxicology and Addiction Medicine, Cooper University Healthcare

Rachel_20Haroz.jpgRachel Haroz MD FAACT is Assistant Professor in the Department of Emergency Medicine at Cooper Medical School of Rowan University.  She is board certified in Emergency Medicine, Medical Toxicology and Addiction Medicine, obtaining her BA in Biology from Brandeis University, her MD from Tufts University and completed a residency in Emergency Medicine and fellowship in Medical Toxicology at MCP/Hahnemann. She has spent the last 17 years working in inner city emergency departments, mostly in the Camden area where opioid intoxication, abuse and dependency are rampant.  She helped launch and now staffs the Outreach Clinic at the Urban Health Institute at Cooper University Hospital in Camden New Jersey, an addiction medicine specialty clinic dedicated to treating patients with substance use disorders as well as the Early Intervention Program Clinic – a clinic dedicated to the care of patients with HIV and substance use disorders.  In the last 2 years she helped created and implement an initiative to prescribe buprenorphine from the Emergency Department and bridge patients to treatment.  She is also heavily involved in education of residents, medical students and pharmacists and organizes education forums focused on topics related to opioid dependency and treatment, having received grant funding to achieve this.  She works closely with local government and emergency provider organizations such as the EMS staff and the Camden County Addiction Drug Task Force in both education and intervention initiatives.

Shaun Hopkins, BSW

Manager, The Works, Toronto Public Health; Manager, Needle Exchange, Toronto Public Health at City of Toronto

20161019_142723.jpgShaun is an expert in harm reduction and has been the Manager of The Works harm reduction program  at Toronto Public Health for 28 years.  During her time at The Works, she implemented the first public health operated opioid substitution program in Canada, the first Canadian public health run naloxone program and the first public health operated supervised injection service in Ontario.  She has co-authored several articles on harm reduction, was involved in the development of Best Practices for harm reduction programs in Canada and best practice guidelines for nursing services in supervised consumption services.  She has also been involved in several research studies in the field of harm reduction including in the areas of supervised consumption, naloxone distribution, HIV and general harm reduction research.  Since August, 2017, Shaun has operated a supervised injection service in the heart of downtown Toronto.  The service is one of the busiest in Toronto, with over 50,000 visits and almost 1000 overdoses in the first 2 years of operation.

Jessica Kattan, MD, MPH

Director, Primary Care Integration Unit, Bureau of Alcohol and Drug Use Prevention, Care and Treatment, New York City Department of Health and Mental Hygiene

headshot_2017_kattan.jpgDr. Jessica Kattan is the Director of Primary Care Integration at the New York City Department of Health and Mental Hygiene’s Bureau of Alcohol and Drug Use Prevention, Care and Treatment. Dr. Kattan received her medical degree from Yale School of Medicine and her Masters in Public Health from Harvard School of Public Health. She trained in primary care/internal medicine, and then in medical epidemiology with CDC’s Epidemic Intelligence Service. Her current work focuses on increasing access to buprenorphine treatment for opioid use disorder, promoting judicious opioid and benzodiazepine prescribing, and enhancing substance use-related education among clinical trainees in New York City.

Andrew Kolodny, MD

Senior Scientist, Institute for Behavioral Health; Co-Director of Opioid Policy Research, Heller School for Social Policy and Management, Brandeis University

A_Kolodny_headshot.pngDr. Andrew Kolodny is one of the nation's leading experts on the prescription opioid and heroin crisis. He is Co-Director of the Opioid Policy Research Collaborative at the Heller School for Social Policy and Management at Brandeis University.
Dr. Kolodny previously served as Chief Medical Officer for Phoenix House, a national nonprofit addiction treatment agency and Chair of Psychiatry at Maimonides Medical Center in New York City. Dr. Kolodny has a long-standing interest in public health. He began his career working for the New York City Department of Health and Mental Hygiene in the Office of the Executive Deputy Commissioner. For New York City, he helped develop and implement multiple programs to improve the health of New Yorkers and save lives, including city-wide buprenorphine programs, naloxone overdose prevention programs and emergency room-based screening, brief intervention and referral to treatment (SBIRT) programs for drug and alcohol misuse.

JoAn Laes, MD

Addiction Medicine Physician, Hennepin Healthcare

Laes.pngJoAn Laes, MD, Attending Physician, Division of Addiction Medicine, Hennepin County Medical Center, Minneapolis, MN; Core Medical Toxicology Faculty, Minnesota Poison Control System, Minneapolis, MN; Medical Director, Mission Detox Center, Plymouth, MN and 1800 Detox, Minneapolis, MN, ASAM Medical Toxicology Workgroup Chair, ACMT Addiction Medicine Committee Co-chair
Dr. Laes' practice is focused on inpatient addiction medicine and toxicology consultation and outpatient treatment of opioid and other substance use disorders. She is board certified in Internal Medicine, Addiction Medicine, and Medical Toxicology. She completed internal medicine residency at Hennepin Healthcare and medical toxicology fellowship at Regions Hospital in St. Paul, Minnesota.

Petros Levounis, MD, MA

Professor and Chair, Department of Psychiatry, Rutgers New Jersey Medical Center 

Petros_Levounis_1.jpgPetros Levounis, MD, MA, serves as professor and chair of the Department of Psychiatry at Rutgers New Jersey Medical School, and chief of service at University Hospital in Newark, New Jersey.
Dr. Levounis is a Phi Beta Kappa graduate of Stanford University where he studied chemistry and biophysics before receiving his medical education at Stanford University School of Medicine and the Medical College of Pennsylvania. During medical school, he researched the effects of social class on patient-physician relationships in Oxford, England, and received an MA degree in sociology from Stanford. In 1994, he moved to New York City to train in psychiatry at the New York State Psychiatric Institute of Columbia University. He graduated from Columbia earning the National Institute of Mental Health Outstanding Resident Award and went on to complete his fellowship in addiction psychiatry at New York University.
Dr. Levounis is a Betty Ford Scholar, a recipient of a U.S. State Department Speaker and Specialist Award, a distinguished fellow of the APA and ASAM, and an honorary member of the World Psychiatric Association.
Dr. Levounis has published thirteen books including the self-help paperback “Sober Siblings: How to Help Your Alcoholic Brother or Sister—and Not Lose Yourself.” Dr. Levounis is currently working on a Pocket Guide to LGBTQ Mental Health and the first Textbook of Technological Addictions. Several of his books have been translated into French, German, Hungarian, Japanese, Portuguese, and Spanish.
Dr. Levounis is married to actor Lukas Hassel and lives in New York City.

Eugenia C. South, MD, MS

Assistant Professor of Emergency Medicine, Perelman School of Medicine, University of Pennsylvania

Gina_bratram_garden_talk_5.jpgEugenia South, MD, MSHP is an Assistant Professor of Emergency Medicine at the Perelman School of Medicine at the University of Pennsylvania. Dr. South's research focuses on how neighborhood context impacts health and safety in urban environments. She is particularly interested in urban nature as an untapped health promotion tool. Her current research portfolio includes a behavioral-economics informed intervention to encourage postpartum women to spend time in local nature to prevent postpartum depression, and designing and testing the impact of new urban micro-green space interventions on mental health and wellness. Additionally, she is interested in understanding the ways in which other neighborhood environment factors – for example housing quality, noise, and blighted spaces influence chronic stress, cardiovascular and mental health, substance abuse, and violent crime. She has worked on a series of studies evaluating the impact of vacant lot greening on violent crime, perceptions of safety, physiologic stress, and mental health. This work has been published in JAMA Network Open, PNAS, and AJPH, and has been featured in national and international media outlets including NPR, NBC News, TIME, and the Philadelphia Inquirer. Dr. South received her MD from Washington University School of Medicine in 2008 and her MSHP from the University of Pennsylvania in 2012, during which time she was also a Robert Wood Johnson Clinical Scholar.

Judy Staffa, PhD, RPh

Associate Director for Public Health Initiatives, Office of Surveillance & Epidemiology, Center for Drug Evaluation and Research (CDER), US Food and Drug Administration (FDA)

Staffa_headshot.jpgJudy Staffa, Ph.D., R.Ph., is the Associate Director for Public Health Initiatives at FDA, Center for Drug Evaluation and Research (CDER), Office of Surveillance and Epidemiology (OSE), where she is responsible for setting strategic direction for complex, multidisciplinary reviews related to opioid abuse – from a planning, scientific, and policy point of view. Prior to this role, Judy was the Director, Division of Epidemiology II, directing the regulatory review and research work of epidemiologists in CDER. She has spent her FDA career serving in various roles as the office has evolved over the years. While in the role of the Associate Director for Regulatory Research she assisted in building OSE’s epidemiologic research program, and prior to that she was an epidemiology reviewer and a drug utilization analyst team leader. Before joining FDA in 1999, Judy was a researcher at The Degge Group for ten years, conducting numerous pharmacoepidemiologic studies using both administrative claims data and electronic medical records data to investigate drug safety issues. Judy is a registered pharmacist who received her bachelor’s degree in pharmacy from the University of Connecticut. She practiced community pharmacy prior to receiving her training in public health. She holds a master’s degree in behavioral sciences from the Harvard School of Public Health, and a doctoral degree in epidemiology from the Johns Hopkins Bloomberg School of Public Health.

Sarah E. Wakeman, MD, FASAM

Medical Director, Mass General Substance Use Disorder Initiative; Assistant Professor of Medicine, Harvard Medical School

wakeman_photo_2.jpgSarah E. Wakeman, MD is the Medical Director for the Mass General Hospital Substance Use Disorder Initiative, program director of the Mass General Addiction Medicine fellowship, and an Assistant Professor of Medicine at Harvard Medical School. She is also the Medical Director of the Mass General Hospital Addiction Consult Team, co-chair of the Mass General Opioid Task Force, clinical co-lead of the Partners Healthcare Substance Use Disorder Initiative, and co-chair of the Partners Healthcare Opioid Steering Committee. She is the Chief Medical Officer of RIZE Massachusetts, a nonprofit foundation working to address the opioid overdose crisis.
She received her A.B. from Brown University and her M.D. from Brown Medical School. She completed residency training in internal medicine and served as Chief Medical Resident at Mass General Hospital. She is a diplomate and fellow of the American Board of Addiction Medicine and board certified in Addiction Medicine by the American Board of Preventive Medicine. She is chair of the policy committee for the Massachusetts Society of Addiction Medicine. She served on Massachusetts' Governor Baker’s Opioid Addiction Working Group. Nationally, she served as chair of the American Society of Addiction Medicine Drug Court Task Force and serves on their Ethics Committee.
Clinically she provides specialty addiction and general medical care in the inpatient and outpatient setting at Mass General Hospital and the Mass General Charlestown Health Center. Her research interests include evaluating models for integrated substance use disorder treatment in general medical settings, low threshold treatment models, recovery coaching, physician attitudes and practice related to substance use disorder, and screening for substance use in primary care.

 

2020 ACMT Annual Scientific Meeting

Ann Arens, MD

Medical Toxicologist, Emergency Medicine Physician; Hennepin Healthcare, Minnesota Poison Control System

Arens_Headshot.jpgDr. Arens is a medical toxicologist at the Minnesota Poison Control System and Hennepin Healthcare in Minneapolis, MN. She is also an emergency medicine physician at Hennepin County Medical Center and an Assistant Professor of emergency medicine at the University of Minnesota. She completed her emergency medicine residency at the Denver Health Residency in Emergency Medicine and her fellowship in medical toxicology at the University of California - San Francisco. Her research interests include drugs of abuse, identification of novel drugs of abuse, opioids, and use of antidotes.

Dazhe James Cao, MD

Assistant Professor of Emergency Medicine, Program Director of Medical Toxicology, UT Southwestern

cao-dazhe_cropped_.jpgDr. James Cao, MD, FACEP is currently an assistant professor of emergency medicine and the program director for the medical toxicology fellowship at UT Southwestern Medical Center. He graduated from the emergency medicine residency at Carolinas Medical Center in Charlotte, NC and then completed a medical toxicology fellowship at Rocky Mountain Poison and Drug Safety in Denver, CO. His academic interests are in teaching and curriculum development. He has published on a range of topics including laboratory interference, lipid emulsion therapy, marijuana, and toxic alcohols.

Arthur L. Caplan, PhD

Director, Division of Medical Ethics, New York University School of Medicine

Unknown.pngCurrently the Drs. William F and Virginia Connolly Mitty Professor and founding head of the Division of Medical Ethics at NYU School of Medicine in New York City.
Prior to coming to NYU School of Medicine, Dr. Caplan was the Sidney D. Caplan Professor of Bioethics at the University of Pennsylvania Perelman School of Medicine in Philadelphia, where he created the Center for Bioethics and the Department of Medical Ethics. Caplan has also taught at the University of Minnesota, where he founded the Center for Biomedical Ethics, the University of Pittsburgh, and Columbia University. He received his PhD from Columbia University.
Dr. Caplan is the author or editor of thirty-five books and over 750 papers in peer reviewed journals. His most recent books are The Ethics of Sport, (Oxford University Press, 2016 with Brendan Parent), Vaccination Ethics and Policy, (MIT Press, 2017 with Jason Schwartz) and Getting to Good: Research Integrity in Biomedicine Springer, 2018 with Barbara Redman).

Neeraj Chhabra, MD

Attending Physician, Cook County Health and Hospitals System

chhabra_headshot.jpgNeeraj Chhabra, M.D, is an Emergency Medicine physician and Medical Toxicologist at Cook County Hospital in Chicago, IL and an Assistant Professor of Emergency Medicine at Rush Medical College. Dr. Chhabra earned his M.D. degree from Jefferson Medical College in Philadelphia, PA. He completed his residency in Emergency Medicine at Cook County Hospital and subsequently completed a fellowship in Medical Toxicology under the guidance of the Toxikon Consortium through Cook County Hospital, the University of Illinois in Chicago Hospital, and the Illinois Poison Center. He currently works as a consultant for the Illinois Poison Center and as the Director of the Academic Associates Research Program within the Department of Emergency Medicine at Cook County Hospital.

Michael Crane, MD, MPH

Medical Director World Trade Center Health Program Clinical Center of Excellence at Mount Sinai Professor, Department of Environmental Medicine and Public Health

Crane_Michael_Photo.jpgDr. Michael Crane is Professor in the Department of Environmental Medicine and Public Health at the Icahn School of Medicine at Mount Sinai, Medical Director of the Selikoff Centers for Occupational Health and of the World Trade Center Health Program Clinical Center of Excellence at Mount Sinai. Dr. Crane is an expert on the physical and mental health consequences of large-scale disasters experienced by rescue and recovery workers, particularly those affecting responders who worked at the World Trade Center disaster site following the attacks of September 11, 2001.

Miriam Dinatale, DO, LCDR, USPHS

Chief Medical Officer, US Food and Drug Administration

PHS_photo.jpgDr. Miriam Dinatale is a Maternal Health team leader in the Division of Pediatric and Maternal Health at the Food and Drug Administration (FDA) in Silver Spring, Maryland and has held this position since 2016. As a team leader of the Maternal Health Team, she oversees quality initiatives that improve pregnancy and lactation-related information in prescription medication labeling. Dr. Dinatale began working at the FDA as a medical officer in the Division of Pediatric and Maternal Health in 2013. She received her medical degree from the New York Institute of Technology College of Osteopathic Medicine in 2006 and completed her residency training in Family Medicine at Malcolm Grow Medical Center, Joint Base Andrews in Maryland in 2009. Dr. Dinatale is board certified in Family Medicine. She served as a family practice physician and officer in the United States Air Force from 2006 to 2013. In November 2013, Dr. Dinatale entered the U.S. Public Health Service as a commissioned officer.

Stevan Emmett, MBChB, D.Phil

Principal Medical Officer and Senior Clinical Fellow, Defence Science and Technology Laboratory

no_image.pngDr. Steve Emmett is Principal Medical Officer at Defence Science and Technology Laboratory, Porton Down and is a Consultant Pharmaceutical Physician specialising in Toxicology and CBRN medicine. He has responsibilities as a medical advisor to the advance development programme delivering future therapeutic interventions, MedCM, for chemical and biological threats. Steve supports medical aspects of research and development across the Dstl portfolio, is deputy chair of the Scientific Advisory committee and sits on the UK Advisory Group on Military and Emergency Response Medicine. To date Steve continues to practice clinically in Emergency Medicine where he is Senior Clinical Fellow in Emergency Medicine at Royal United Hospitals NHS Foundation Trust, Bath and is honorary Senior Lecturer at the University of Bristol

Bryan Judge, MD, FACMT

Professor of Emergency Medicine, Michigan State University College of Human Medicine, Grand Rapids Medical Education Partners

Judge_Photo.jpg
Bryan S. Judge, MD, FACMT, is an emergency medicine physician and medical toxicologist and practices in Grand Rapids, MI, and Laurium, MI. He graduated from Wayne State University School of Medicine in Detroit, MI and completed his residency in emergency medicine in Grand Rapids at the Grand Rapids Medical Education & Research Center | Michigan State University, and his medical toxicology fellowship at Indiana University | Indiana Poison Center in Indianapolis, IN.

He is currently a Professor in the Department of Emergency Medicine, Michigan State University | College of Human Medicine. Academic interests include a broad array of topics within the disciplines of emergency medicine, medical toxicology, and medical education. His most fascinating scientific achievement is helping ‘discover’ a new poisonous mushroom species, Cortinarius orellanosus.

When not in search of another mountain hunting adventure across the globe, you’ll find him enjoying his family, friends, or occasionally the complexities of a fine scotch.

Katherine Katzung, MD, FASAM

Vice Chair, Emergency Department, Abbott Northwestern Hospital

Katzung.jpgKatherine Katzung, MD is an attending physician in the emergency department at Abbott Northwestern, where she serves as vice chair of the department as well as a consultant for the Minnesota Poison Control System and assistant medical director of Mission Detox Center in Plymouth, MN. She recently received grant funding to initiate a hospital-based toxicology/addiction medicine consult service and an ED-based addiction medicine "bridge" clinic to provide continuity of care for patients on medication assisted therapies while transitioning to community-based management.
A graduate of the University of Minnesota School of Medicine, she completed emergency medicine training at Regions Hospital in St. Paul and additional fellowship training in medical toxicology. She is board certified in emergency medicine, medical toxicology, and addiction medicine. Her clinical interests surround the intersection of these 3 specialties, with special focus on early ED & hospital-based interventions to evaluate and treat substance use disorder, including initiation of medication assisted therapies.

Eric J. Lavonas, MD, MS, FAACT, FACMT, FACEP

Professor of Emergency Medicine, Denver Health

Lavonas_head_shot_white_coat_cropped_2018-05.jpgDr. Lavonas is a medical toxicologist and emergency physician at Denver Health Medical Center and Professor of Emergency Medicine at the University of Colorado. He is a member of the Faculty Promotions Committee of the CU Anschutz Medical Campus and President of the Denver Health Medical Staff. His core interests are snake envenomation, resuscitation, and medication safety.

Daniel J. Sessions, MD

Medical Toxicologist, Emergency Care Consultants, Addiction & Toxicology

no_image.pngDr. Sessions completed medical school at LSU School of Medicine - New Orleans on the Army Health Professions Scholarship. He completed his emergency medicine residency and chief residency at Brooke Army Medical Center. He completed his medical toxicology fellowship at the Rocky Mountain Poison & Drug Center in Denver, Colorado. He has served as Chief of the Clinical Toxicology Service at Brooke Army Medical Center and Associate Program Director of the Emergency Medicine Residency. He has provided toxicology teleconsultation for the Department of Defense ADVISOR program since its inception. He currently serves as a medical toxicologist at the South Texas Poison Center and Minnesota Poison Control System. He currently practices addiction medicine and toxicology with Emergency Care Consultants in Minneapolis, MN. His areas of interest are envenomations, performance-enhancing substances and supplements, and addiction medicine.

CDR Emily Thakur, RPh

Team Leader, US Food & Drug Administration

Screen_Shot_2019-10-07_at_1_17_10_PM.pngCDR Emily Thakur, R.Ph., is a Team Leader with the Drug Shortage Staff at the FDA.  She joined the FDA in 1999 as a Consumer Safety Officer for the Regulatory Support Branch in the Office of Generic Drugs.  She then joined the Office of Regulatory Policy in the Center for Drug Evaluation and Research in 2005.  She has been in her current position, with the Drug Shortage Staff since February 2011.  Prior to joining the FDA, she held a position as a staff pharmacist with CVS/Pharmacy and held a part-time position until 2014.  She received her Bachelor of Science degree from Rutgers College of Pharmacy in 1999.

Simon Thomas, MD

Professor of Clinical Pharmacology and Therapeutics and NHS Foundation Trust, Newcastle University

Simon_Thomas.jpgProfessor Simon Thomas is Professor of Clinical Pharmacology and Therapeutics at Newcastle University, clinical lead of the UK National Poisons Information Service and a past President of the European Association of Poisons Centres and Clinical Toxicologists. He works with relevant UK agencies in planning response to mass casualty events and is responsible for provision of specialist clinical advice for the management of unusual or severe poisonings.

Laura M. Tormoehlen, MD

Associate Professor of Clinical Neurology and Emergency Medicine-Toxicology, Indiana University

Tormoehlen_Laura_Faculty_Picture.jpgComing soon.

Robert O. Wright, MD, MPH

Professor and Ethel H Wise Chair, Department of Environmental Medicine & Public Health, Icahn School of Medicine at Mt. Sinai

Screen_Shot_2019-10-07_at_1_16_47_PM.pngDr. Robert Wright is a pediatrician, medical toxicology and environmental epidemiologist. Chair of the Department of Environmental Medicine and Public Health at the Icahn School of Medicine at Mount Sinai in New York City. He is also the founding director of the Mount Sinai Institute for Exposomic Research, an interdisciplinary program dedicated to studying all the health relevant environmental factors we experience across the life course. Exposomics is a new big data science that touches on nutrition, physical activity, chemicals, social environment and the physical environment. He is one of few than 50 pediatricians board certified in Medical Toxicologist and trained in genetic and environmental epidemiology at Harvard University. He is the Director of the Lautenberg Laboratory of Environmental Health Science, and is the Principal Investigator of both a NIH CHEAR Lab Hub grant and a NIH P30 Core Center grant. He has received His research is dedicated to the effects of toxic chemicals and air pollution on child health. He is also the Principal Investigator of an ongoing birth cohort study also funded by the National Institute of Environmental Health Sciences call PROGRESS (Programing Research in Obesity, GRowth, Environment and Social Stress). This study is based in Mexico City and is a collaboration with the National Institute of Public Health, Mexico. His research expertise is in the field of exposomics and the integration of environmental measures with genomics in understanding neurodevelopment. He studies environment broadly and has published extensively on the role of psychosocial factors as modifiers of chemical toxicity.

Paul Wax, MD, FACMT

Executive Director, American College of Medical Toxicology

Wax_Paul.jpgDr. Wax is the Executive Director of the American College of Medical Toxicology. He received his B.A from Dartmouth College, his M.D. from the Mount Sinai School of Medicine, his Emergency Medicine training at the UCLA Hospitals, and his Medical Toxicology training at Bellevue Medicine Center / New York University. He is Board-certified in both Medical Toxicology and Emergency Medicine, and is a Fellow of the American College of Medical Toxicology.
 
Along with his part time role as the Executive Director of ACMT, Dr. Wax is a Clinical Professor in Surgery (Emergency Medicine) at the University of Texas, Southwestern School of Medicine where he is a member of the Section of Medical Toxicology and Director of the Medical Toxicology Clinic. Before joining ACMT in 2008 as its Executive Director, and the University of Texas Southwestern in 2006 as a part-time faculty member, Dr. Wax had faculty appointments in the Departments of Emergency Medicine at the University of Rochester School of Medicine from 1991-2001 and the University of Arizona School of Medicine from 2001-2006. Dr. Wax previously served on the Board of Directors of ACMT from 1998-2008 serving as ACMT President from 2006-2008. During this tenure he chaired the ACMT Education Committee from 1998-2002. From 2002-2006 Dr. Wax served as the National Director of ACMT's Consultation Network to support the ATSDR Regional Offices and was co-founder of ACMT’s Chemical Agent of Opportunity course. From 1997-2006 Dr. Wax also served as one of the American Board of Emergency Medicine’s appointee’s on the Medical Toxicology Subboard. During this time Dr. Wax served as Editor of the Medical Toxicology Board Certification Examination as well as Chairman of the Subboard, and was also the primary author of the 2004 Core Content of Medical Toxicology. Dr. Wax has also served as a consultant to the Centers for Disease Control NCEH’s Division of Laboratory Sciences and was a member of NCEH/ATSDR Board of Scientific Counselors from 2006-2008.